Literature DB >> 23614337

NX-PVKA assay, a conventional but refined prognostic biomarker for hepatocellular carcinoma.

Naoya Sakamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23614337     DOI： 10.1111/jgh.12138

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  3 in total

1.  Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.

Authors:  Akiko Sumi; Jun Akiba; Sachiko Ogasawara; Masamichi Nakayama; Yoriko Nomura; Makiko Yasumoto; Sakiko Sanada; Osamu Nakashima; Toshi Abe; Hirohisa Yano
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

2.  Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line.

Authors:  Sachiko Ogasawara; Masamichi Nakayama; Jun Akiba; Hironori Kusano; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

3.  Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis.

Authors:  Yue Chang; Baiqing Liu; Haiyan Niu; Zhenguo Wang; Shihai Xia; Hai Li
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.